Showing 37–48 of 68 results

Bevacizumab

Dilution: the original commercial, therapeutic drug is diluted to a laboratory-friendly 1 mg/ml final concentration. The dilutant is PBS pH 7.4. No preservatives added, so please open under sterile conditions or aliquote into smaller fractions. All diluted therapeutic molecules are stored at -80°C. Products can be shipped on dry ice or on gel-packs.

Etanercept

332,00 

Therapeutic TNF-α-inhibitor from the original Enbrel commercial drug targeting the TNF-α-antigen.

Adalimumab

610,00 

Therapeutic TNF-α-antibody from the original Humira commercial drug targeting the TNF-α-antigen, also referred to as Humira antibody.

Aflibercept

604,00 

Therapeutic TNF-α-antibody from the original Humira commercial drug targeting the TNF-α-antigen, also referred to as Humira antibody.

Obinutuzumab

748,00 

Therapeutic CD20-antibody from the original Gazyvaro commercial drug targeting the CD20-antigen, also referred to as Gazyvaro antibody.

Pembrolizumab

825,00 

Therapeutic PD-1-antibody from the original Keytruda commercial drug targeting the PD-1-antigen, also referred to as Keytruda antibody.